IL-6 release after intestinal ischemia/reperfusion in rats is under partial control of TNF

Journal of Surgical Research

Volumn 70, Issue 1, 1997, Pages 21-26

  Yao, Yong Ming ^a   Bahrami, Soheyl ^a   Redl, Heinz ^a   Fuerst, Shayesteh ^a   Schlag, Guenther ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INTESTINE ISCHEMIA; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SEPTIC SHOCK;

EID: 0031171774     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5074     Document Type: Article

References (39)

1. Bahrami S., Schlag G., Yao Y. M., Redl H. Significance of translocation/endotoxin in the development of systemic sepsis following trauma and/or hemorrhage. Prog. Clin. Biol. Res. 392:1995;197.
2. Bahrami S., Redl H., Yao Y.-M., Schlag G. Involvement of bacteria/endotoxin translocation in the development of multiple organ failure. Curr. Top. Microbiol. Immunol. 216:1996;239.
3. Cabie A., Farkas J. C., Fitting C., Laurian C., Cormier J. M., Carlet J., Cavaillon J. M. High levels of portal TNF-a during abdominal aortic surgery in man. Cytokine. 5:1993;448.
4. Yao Y. M., Bahrami S., Leichtfried G., Redl H., Schlag G. Pathogenesis of hemorrhage-induced bacteria-endotoxin translocation in rats: Effects of recombinant bactericidal-increasing protein (rBPI21). Ann. Surg. 221:1995;398.
5. Deitch E. A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch. Surg. 125:1990;403.
6. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J. I., Zentella A., Albert J. D., Shires G. T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470.
7. Schlag G., Redl H., Davies J., Haller I. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 2:1994;10.
8. Roumen R. M., Hendriks T., van der Ven Jongekrijg J., Nieuwenhuijzen G. A., Sauerwein R. W., van der Meer J. W., Goris R. J. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218:1993;769.
9. Jiang J. X., Bahrami S., Leichtfried G., Redl H., Oehlinger W., Schlag G. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation following hemorrhagic shock in rats. Ann. Surg. 221:1995;100.
10. Yao Y. M., Sheng Z. Y., Yu Y., Tian H. M., Wang Y. P., Lu L. R., Xu S. H. The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury. Resuscitation. 29:1995;157.
11. Caty M. G., Guice K. S., Oldham K. T., Remick D. G., Kunkel S. I. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann. Surg. 212:1990;694.
12. Yao Y. M., Bahrami S., Redl H., Schlag G. Monoclonal antibody to tumor necrosis factor alpha attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats. Crit. Care Med. 24:1996;1547.
13. Fong Y., Tracey K. J., Moldawer L. L., Hesse D. G., Manogue K. B., Kenney J. S., Lee A. T., Kuo G. C., Allison A. C., Lowry S., Cerami A. Antibodies to cachectin tumor necrosis factor reduce interleukin 1a and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1989;1627.
14. Schluter B., Konig B., Bergmann U., Muller F. E., Konig W. Interleukin 6 - A potential mediator of lethal sepsis after major thermal trauma: Evidence for increased IL-6 production by peripheral blood mononuclear cells. J. Trauma. 31:1991;1663.
15. Shalaby M. R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor-alpha, and interleukin 1 induce interleukin 6 productionin vivo. Clin. Immunol. Immunopathol. 53:1989;488.
16. Otamiri T. Quinacrine prevention of intestinal ischaemic mucosal damage is partly mediated through inhibition of intraluminal phospholipase A2. Agents Actions. 25:1988;378.
17. Suitters A. J., Foulkes R., Opal S. M., Palardy J. E., Emtage J. S., Rolfe M., Stephens S., Morgan A., Holt A. R., Chaplin L. C. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. J. Exp. Med. 179:1994;849.
18. Bahrami S., Leichtfried G., Redl H., Schlag G. A kinetic chromogenic method to determine endotoxin on microplates. Eur. Clin. Lab. News. Oct. 8 1991.
19. Von Asmuth E. J., Maessen J. G., Van der Linder C. J., Buurman W. A. Tumor necrosis factor-alpha (TNF) and interleukin 6 in a zymosan induced shock model. Scand. J. Immunol. 32:1990;313.
20. Sachs L. Statistische Methoden 2: Planung und Auswertung. 1990;Springer Verlag, Berlin, Heidelberg.
21. Koike K., Moore E. E., Moore F. A., Carl V. S., Pitman J. M., Banerjee A. Phospholipase A2 inhibition decouples lung injury from gut ischemia-reperfusion. Surgery. 112:1992;173.
22. Squadrito F., Altavilla D., Ioculano M., Calapai G., Zingarelli B., Saitta A., Campo G. M., Rizzo A., Caputi A. P. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock. Circ. Shock. 37:1992;236.
23. Redl H., Schlag G., Schiesser A., Davies J. Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons. Am. J. Physiol. 264:1993;H2119.
24. Sharma R. J., Macallan D. C., Sedgwick P., Remick D. G., Griffin G. E. Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-alpha monoclonal antibody. Am. J. Physiol. 262:1992;R786.
25. Dhainaut J. F., Vincent J. L., Richard C., Lejeune P., Martin C., Fierobe L., Stephens S., Ney U. M., Sopwith M. CDP571, a humanized antibody to human tumor necrosis factor-alpha: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit. Care Med. 23:1995;1461.
26. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265:1990;621.
27. Shalaby M. R., Waage A., Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell. Immunol. 121:1989;372.
28. McCurry K. R., Campbell D. A. Jr., Scales W. E., Warren J. S., Remick D. G. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J. Surg. Res. 55:1993;49.
29. Engelberts I., Von Asmuth E. J., Van der Linden C. J., Buurman W. A. The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res. 10:1991;127.
30. DeForge L. E., Kenney J. S., Jones M. L., Warren J. S., Remick D. G. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148:1992;2133.
31. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., Mantovani A. IL-. 1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:1989;549.
32. Suzuki S., Toledo Pereyra L. H. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J. Surg. Res. 57:1994;253.
33. Grotz M. R., Ding J., Guo W., Huang Q., Deitch E. A. Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock. 3:1995;362.
34. Shenkin A., Fraser W. D., Seris J., Winstanley F. P., McCartney A. C., Burns H. J., vanDamme J. The serum interleukin-6 responses to elective surgery. Lymphokine Res. 8:1989;123.
35. Deitch E. A., Dazhong X., Franko L., Ayala A., Chaudry I. H. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1:1994;141.
36. Wortel C. H., van Deventer S. J., Aarden L. A., Lygidakis N. J., Buller H. R., Hoek F. J., Horikx J., ten Cate J. W. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 114:1993;564.
37. Wozasek G. E., Thurnher M., Redl H., Schlag G. Pulmonary reaction during intramedullary fracture management in traumatic shock: An experimental study. J. Trauma. 37:1994;249.
38. Ayala A., Knotts J. B., Ertel W., Perrin M. M., Morrison M. H., Chaudry I. H. Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch. Surg. 128:1993;89.
39. Gennari R., Alexander J. W., Pyles T., Hartmann S., Ogle C. K. Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis. Arch. Surg. 129:1994;1191.